STOCK TITAN

Encompass Health Corporation - EHC STOCK NEWS

Welcome to our dedicated page for Encompass Health Corporation news (Ticker: EHC), a resource for investors and traders seeking the latest updates and insights on Encompass Health Corporation stock.

Encompass Health Corporation (NYSE: EHC) is a leading provider of post-acute healthcare services in the United States. Specializing in inpatient rehabilitation, the company operates a network of 161 hospitals across 37 states and Puerto Rico. These hospitals offer comprehensive rehabilitative care for patients recovering from major injuries and illnesses, including strokes, brain injuries, spinal cord injuries, and complex orthopedic conditions.

Encompass Health's business model revolves around delivering high-quality, cost-effective care through both facility-based and home-based patient care. The company's integrated approach includes advanced therapies, customized treatment plans, and coordinated care teams to ensure optimal patient outcomes. Their commitment to excellence is reflected in their significant market presence and continual expansion. Recent projects include new inpatient rehabilitation hospitals in Avondale, Arizona, and San Antonio, Texas, aimed at enhancing their service offerings.

Financially, Encompass Health has demonstrated robust performance with consistent revenue growth. For instance, the company reported a 13.4% revenue growth in Q1 2024, driven by strong discharge growth and efficient expense management, leading to an Adjusted EBITDA growth of 19.2%. Their strategic focus on improving labor costs and operational efficiency continues to bolster their financial health.

Encompass Health's dedication to innovation is evident in their use of advanced rehabilitation technologies and their commitment to ongoing research. The company recently announced a call for research grant applications, aimed at investigating the effectiveness of therapies in post-acute care settings. This initiative underscores their commitment to enhancing patient care through evidence-based practices.

Recognized as one of Fortune's World's Most Admired Companies and Modern Healthcare's Best Places to Work in Healthcare, Encompass Health prioritizes a positive working environment for its staff, ensuring they are equipped with the necessary tools and support to deliver exceptional patient care.

For the latest updates on Encompass Health Corporation, including their quarterly earnings reports, new hospital developments, and research initiatives, visit their investor website or follow their official social media channels.

Rhea-AI Summary

Encompass Health Corporation (NYSE: EHC) announced on December 16, 2021, that it has received consents from holders of its 5.75% Senior Notes due 2025 for proposed amendments, completed on December 15, 2021. The amendments will proceed if a consent payment is made. Additionally, the company is extending the consent solicitation for holders of its 4.500%, 4.750%, and 4.625% Senior Notes, now expiring on January 12, 2022. All other terms remain unchanged, and the company retains the right to modify or terminate the solicitation at any time.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.72%
Tags
none
-
Rhea-AI Summary

Encompass Health Corp. (NYSE: EHC) announced plans to establish a 40-bed inpatient rehabilitation hospital in Strongsville, Ohio, aimed at enhancing patient access to rehabilitation services in the Cleveland area. This facility will cater to patients recovering from conditions such as strokes and spinal cord injuries, and will provide services including 24-hour nursing care and various therapies. The construction timeline is yet to be announced. Currently, Encompass Health operates four inpatient rehabilitation hospitals in Ohio, indicating its commitment to expanding its national healthcare network.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.69%
Tags
none
-
Rhea-AI Summary

Encompass Health Corporation (NYSE: EHC) announced a Consent Solicitation on December 9, 2021, seeking approval from holders of its Senior Notes for proposed amendments to facilitate the separation of its home health and hospice business, expected in H1 2022. The amendments aim to allow a spin-off contingent upon maintaining a consolidated net leverage of no more than 3.5 to 1.0. Consent will expire on December 15, 2021, with cash payments for valid consents ranging from $2.50 to $5.00 per $1,000 depending on the note series. The success of this solicitation is uncertain.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.85%
Tags
none
Rhea-AI Summary

Encompass Health Corp. (NYSE: EHC) has announced plans to construct a new 40-bed inpatient rehabilitation hospital in Amarillo, Texas. This facility will offer specialized care for patients recovering from serious medical conditions such as strokes and spinal cord injuries, featuring private rooms and advanced therapy technologies. The project aims to extend the company's Texas operations, which already includes 26 rehabilitation hospitals. Construction details, including timelines, will be provided later. The new hospital is expected to enhance coordinated care in the region.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.62%
Tags
none
-
Rhea-AI Summary

Encompass Health Corp. (NYSE: EHC) announced plans to construct a 27-bed inpatient rehabilitation hospital in Irmo, South Carolina, near Columbia. The facility is designed for future expansion to 50 beds and will begin construction in Q3 2022, with services expected to commence in Q4 2023. The hospital aims to provide care for patients recovering from serious conditions, including strokes and spinal cord injuries, and will feature private rooms and a specialized therapy gym. This project expands Encompass Health's existing network, which includes eight rehabilitation hospitals in South Carolina.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.09%
Tags
none
-
Rhea-AI Summary

Encompass Health Corporation (NYSE: EHC) reported solid third-quarter results with a 9.4% increase in net operating revenues, reaching $1,284.8 million, compared to $1,173.9 million in Q3 2020. Adjusted EBITDA grew by 6.7% to $245.6 million. EPS from continuing operations rose 28.2% to $1.00. However, the home health and hospice segment faced COVID-related challenges, leading to a decline in revenue and increased costs. Consequently, the company has lowered its full-year guidance for 2021.

Despite challenges, management remains confident in long-term growth.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.8%
Tags
none
Rhea-AI Summary

Encompass Health Corp. (NYSE: EHC) filed a lawsuit against former executive April Anthony in Dallas County, Texas, for breaching her employment agreement. The lawsuit alleges violations of non-competition and non-solicitation clauses, as well as misappropriation of trade secrets. The company reportedly discovered that Anthony secretly encouraged employees, including senior executives, to join a competing venture, activities that began before her departure and continued after. Encompass Health operates an extensive network of healthcare services, with 144 hospitals and 249 home health locations across the U.S.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.23%
Tags
none
-
Rhea-AI Summary

Encompass Health (NYSE: EHC) announces an expansion of its joint venture with Baptist Health South Florida to include Baptist Health's home health agency in Miami. The deal is expected to close in Q4 2021, subject to regulatory approvals. This partnership aims to enhance the quality of home health services in Miami-Dade and Monroe counties, complementing existing rehabilitation services. Encompass Health, a leader in integrated post-acute healthcare, ranks among the top providers of Medicare-certified skilled home health and hospice services.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.25%
Tags
none
-
Rhea-AI Summary

On October 21, 2021, Encompass Health Corporation (NYSE: EHC) announced a quarterly cash dividend of $0.28 per share. This dividend is payable on January 18, 2022, to stockholders on record as of January 3, 2022. Encompass Health operates a vast network of healthcare facilities, including 144 hospitals and numerous home health and hospice locations across the U.S. The company is recognized as one of Fortune's 100 Best Companies to Work For, emphasizing its commitment to quality healthcare services.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.55%
Tags
dividends
Rhea-AI Summary

Encompass Health (NYSE: EHC) and Baptist Health have received a certificate of need to construct a 40-bed inpatient rehabilitation hospital in Louisville, Kentucky. This joint venture is set to begin operations in Q4 2023, replacing an existing 29-bed unit. The new facility will enhance rehabilitation service access in a region with growing demand, serving patients recovering from conditions such as strokes and spinal cord injuries. The collaboration aims to provide specialized care, improving functional abilities and quality of life for patients.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.73%
Tags
none

FAQ

What is the current stock price of Encompass Health Corporation (EHC)?

The current stock price of Encompass Health Corporation (EHC) is $99.465 as of October 31, 2024.

What is the market cap of Encompass Health Corporation (EHC)?

The market cap of Encompass Health Corporation (EHC) is approximately 10.0B.

What services does Encompass Health Corporation provide?

Encompass Health Corporation offers post-acute healthcare services, including inpatient rehabilitation, home health care, and hospice care.

How many hospitals does Encompass Health operate?

Encompass Health operates 161 inpatient rehabilitation hospitals across 37 states and Puerto Rico.

What conditions do Encompass Health hospitals treat?

They treat a range of conditions including strokes, brain injuries, spinal cord injuries, amputations, and complex orthopedic conditions.

What recent developments have been made by Encompass Health?

Recent developments include new hospital projects in Avondale, Arizona, and San Antonio, Texas, and the launch of a research grant program.

How did Encompass Health perform financially in Q1 2024?

Encompass Health reported a 13.4% revenue growth and a 19.2% Adjusted EBITDA growth in Q1 2024.

What recognitions has Encompass Health received?

The company is ranked as one of Fortune's World's Most Admired Companies and Modern Healthcare's Best Places to Work in Healthcare.

How does Encompass Health support its employees?

The company ensures a positive working environment by providing the necessary tools and support for staff to deliver exceptional patient care.

Where can I find the latest news about Encompass Health?

The latest news can be found on their investor website and official social media channels.

What initiatives does Encompass Health have for research?

Encompass Health has launched a research grant program to investigate the effectiveness of therapies in post-acute care settings.

What technologies does Encompass Health use in rehabilitation?

They use advanced rehabilitation technologies and customized treatment plans to maximize patient recovery.

Encompass Health Corporation

NYSE:EHC

EHC Rankings

EHC Stock Data

10.01B
100.63M
1.43%
98.57%
1.2%
Medical Care Facilities
Services-hospitals
Link
United States of America
BIRMINGHAM